Statins, or HMG-CoA reductase inhibitors, are crucial medications for lowering cholesterol levels, thereby reducing the risk of cardiovascular diseases like heart attacks and strokes. They work by inhibiting the enzyme HMG-CoA reductase, essential for cholesterol biosynthesis in the liver. This action primarily decreases low-density lipoprotein (LDL) cholesterol, known as "bad" cholesterol, reducing arterial plaque buildup and the risk of atherosclerosis.
Statins are indicated for primary prevention in individuals with high LDL cholesterol levels who are at increased cardiovascular risk due to factors like age or diabetes. They are also used for secondary prevention in patients with a history of cardiovascular events to prevent further incidents. Additionally, statins manage cholesterol levels in familial hypercholesterolemia, a genetic condition with very high cholesterol levels.
While generally well-tolerated, statins can cause adverse effects such as muscle pain or myopathy, and in rare cases, rhabdomyolysis. They may also lead to mild liver enzyme elevations and a slight increase in diabetes risk. Patients should be informed about potential cognitive effects, although these are rare and reversible. Routine monitoring of liver function and cholesterol levels is recommended to ensure safety.
Patient counseling should emphasize adherence to statin therapy and the importance of lifestyle modifications like a balanced diet and regular exercise. Patients should be educated on recognizing side effects, particularly muscle pain, and the need to report them promptly. Discussing potential drug interactions, including those with grapefruit juice, is also crucial to minimize risks and optimize treatment outcomes.